Chewing gum gives hope for cancer patients

Chewing Gum gives hope for cancer
There is real hope being offered to cancer patients by a simple chewing gum. This certainly is great news for all those who are grappling with cancer and their care givers. Perhaps this is also a road ahead for other ailments too.
The chewing gum is being developed by researchers at the University of Pennsylvania and is designed to target three specific microbes linked to head and neck squamous cell carcinoma (HNSCC):
Human papillomavirus (HPV): A major risk factor for oropharyngeal cancers.
Porphyromonas gingivalis and Fusobacterium nucleatum: Bacteria associated with worse survival rates in oral cancer patients.
It contains two key active ingredients:
FRIL: A protein derived from lablab beans that acts like a "fly trap," binding to viruses like HPV to prevent them from entering cells.
Protegrin-1: An antimicrobial peptide engineered to kill harmful bacteria like P. gingivalis and F. nucleatum.
? Key Research Findings
The results are from ex vivo studies, meaning lab experiments using samples from patients, not clinical trials testing the gum in live human subjects. The findings are promising but preliminary.
Target Microbe
Key Finding
Source
HPV
93% reduction in HPV levels in saliva samples.
Scientific Reports
P. gingivalis & F. nucleatum
Levels reduced to "near zero" (over 99% reduction) with a single dose.
Scientific Reports
Oral Microbiome
The gum selectively targeted harmful bacteria while preserving beneficial oral bacteria.
Scientific Reports

?? Expert Perspectives
The research community views this as an interesting development but emphasizes caution.
Lead researcher, Dr. Henry Daniell: Views the gum as a future adjunct to existing therapies and a potential tool for prophylaxis to reduce infection and transmission.
Immunologist Dr. Paolo Serafini: Highlights the main question mark. The effect may be temporary (perhaps only about an hour), and it's unknown if this transient reduction would have a meaningful clinical impact.
? The Bottom Line
The antiviral chewing gum is a promising area of research for potentially reducing risk factors associated with HNSCC.
The most important things to know are:
It is not a cure or a proven treatment for cancer.
It is not a substitute for the HPV vaccine, which prevents many HPV-related cancers.
The research is in the lab phase, and clinical trials with human patients are still needed to determine if it's truly effective and safe to use.
We hope this will indeed be effective and wish the patients, their families, scientists and doctors all the best.

By Jamuna Rangachari